Why Veeva Systems Stock Surged Today

Shares of Veeva Systems (NYSE: VEEV) surged as much as 9% on Thursday, August 27, 2026, putting the life sciences cloud software company on pace to close at its highest level since late last year, after it delivered a blowout fiscal second-quarter report and raised its full-year outlook.

The Pleasanton, California-based company reported total revenue of $928 million for the quarter ended July 31, up 18% year-over-year and well ahead of Wall Street’s $904-905 million consensus estimate. Non-GAAP earnings per share came in at $2.35, topping analyst expectations of roughly $2.22 by nearly 6%. Non-GAAP operating income of $415.9 million also cleared estimates, with operating margin expanding to 44.8%.

Investors were especially encouraged by management’s commentary on artificial intelligence. CEO Peter Gassner said Vault CRM had “its best quarter ever,” with more than 180 customers now live, including five top-20 biopharma companies.

The company also disclosed that Eli Lilly and Biogen recently committed to Vault CRM, bringing total top-20 commitments to 12 globally, and reaffirmed confidence in maintaining over 70% share of the CRM market. Meanwhile, Veeva Falcon, its new “agentic AI” platform for clinical, regulatory, and safety workflows, is gaining rapid traction, with five early adopters on track for initial go-lives later this year.

Buoyed by the results, Veeva raised its fiscal 2027 revenue guidance to a midpoint of roughly $3.685 billion, up from $3.64 billion previously, and lifted its non-GAAP EPS outlook to about $9.21. Third-quarter guidance also came in above Street expectations.

The rally came amid a broader software-sector surge, with peers Salesforce, CrowdStrike, and Okta also posting strong post-earnings gains, as investor enthusiasm around enterprise AI adoption swept through the group.